Weimin Dong

464 total citations
29 papers, 349 citations indexed

About

Weimin Dong is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Weimin Dong has authored 29 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Weimin Dong's work include Acute Myeloid Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Weimin Dong is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Weimin Dong collaborates with scholars based in China and United States. Weimin Dong's co-authors include Xiaobao Xie, Weiying Gu, Yan Liu, Rong Wang, Feng Zhi, Yun Ling, Xiang-shan Cao, Yilin Yang, Weide Zhong and Biao Wang and has published in prestigious journals such as PLoS ONE, International Journal of Biological Macromolecules and Oncotarget.

In The Last Decade

Weimin Dong

27 papers receiving 343 citations

Peers

Weimin Dong

HEMAT

IMMUN

PRM

Yuandong Zhu China

Wanggang Zhang China

Baodong Ye China

Ting Jiang China

Huijie Miao China

K Nakamura Japan

Yinji Jin China

Elina Zorde‐Khvalevsky Israel

Yuandong Zhu China

Weimin Dong

129 ×0.5

93 ×0.5

36 ×0.6

HEMAT

50 ×1.5

IMMUN

17 ×0.7

PRM

Citations per year, relative to Weimin Dong Weimin Dong (= 1×) peers Yuandong Zhu

Countries citing papers authored by Weimin Dong

Since Specialization

Citations

This map shows the geographic impact of Weimin Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Dong more than expected).

Fields of papers citing papers by Weimin Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimin Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Dong. The network helps show where Weimin Dong may publish in the future.

Co-authorship network of co-authors of Weimin Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Dong. A scholar is included among the top collaborators of Weimin Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Dong. Weimin Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jiahui, et al.. (2024). Predicting prostate adenocarcinoma patients’ survival and immune signature: a novel risk model based on telomere-related genes. Discover Oncology. 15(1). 203–203.

Dong, Weimin, et al.. (2023). Association of ulcerative colitis and acute gastroenteritis with prostate specific antigen: results from National Health and Nutrition Examination Survey from (2009 to 2010) and Mendelian randomization analyses. Frontiers in Nutrition. 10. 1265014–1265014. 1 indexed citations

Cao, Yang, X. Mao, Fei Wang, et al.. (2022). Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance. Frontiers in Oncology. 12. 894279–894279. 4 indexed citations

Cao, Yang, Fei Wang, Naidong Zhang, et al.. (2022). Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy. Leukemia Research. 122. 106949–106949. 5 indexed citations

Dong, Weimin, Sheng-Bang Yang, Zhiming Zhang, et al.. (2022). Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement. Frontiers in Cellular and Infection Microbiology. 12. 1037279–1037279. 13 indexed citations

Zhang, Hui, Shaoyou Liu, Weimin Dong, et al.. (2020). Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential. Journal of Cancer. 12(1). 232–243. 23 indexed citations

Dong, Weimin, Yong Luo, Hui Zhang, et al.. (2020). Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer. International Journal of Nanomedicine. Volume 15. 5545–5559. 5 indexed citations

Wei, Wei, Yanting Guo, Fei Wang, et al.. (2020). Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review. American Journal of Case Reports. 21. e925151–e925151.

Cao, Yang, Yao Li, Yue Liu, et al.. (2019). An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3. Acta Haematologica. 142(2). 98–104. 5 indexed citations

10.

Lü, Jianming, Weimin Dong, Huichan He, et al.. (2018). Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer. International Journal of Biological Macromolecules. 118(Pt A). 599–609. 32 indexed citations

11.

Xie, Xiaobao, Yan Lin, Yang Cao, et al.. (2018). Autologous stem cell transplantation in EBV-positive post-renal transplant refractory multiple myeloma: A case report and literature review. Oncology Letters. 15(5). 7207–7214. 1 indexed citations

12.

Dong, Weimin, et al.. (2018). Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species. International Journal of Molecular Medicine. 42(2). 1106–1115. 5 indexed citations

13.

Han, Zhaodong, Wenjiao Li, Yue Fei, et al.. (2017). Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation. Oncotarget. 8(46). 80295–80302. 21 indexed citations

14.

Wu, Wei, Yan Lin, Lili Xiang, et al.. (2016). Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy. Annals of Hematology. 95(7). 1051–1057. 13 indexed citations

15.

Xie, Xiaobao, Rong Wang, Biao Wang, et al.. (2015). Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. International Journal of Hematology. 102(3). 296–303. 40 indexed citations

16.

Xie, Xiaobao, Wei Wu, Yuandong Zhu, et al.. (2015). Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature. Oncology Letters. 10(5). 2931–2936. 5 indexed citations

17.

Zhi, Feng, Rong Wang, Lian Xue, et al.. (2015). [MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance].. PubMed. 23(1). 29–33. 2 indexed citations

18.

Dong, Weimin, Xiang-shan Cao, Biao Wang, et al.. (2014). Allogeneic Hemopietic Stem Cell Transplants for the Treatment of B Cell Acute Lymphocytic Leukemia. Asian Pacific Journal of Cancer Prevention. 15(15). 6127–6130. 1 indexed citations

19.

Xiang, Lili, Weimin Dong, Rong Wang, et al.. (2014). All-trans retinoic acid enhances the effect of 5-aza-2′-deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell line. Oncology Letters. 8(1). 117–122. 6 indexed citations

20.

Zhi, Feng, Xiang-shan Cao, Xiaobao Xie, et al.. (2013). Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia. PLoS ONE. 8(2). e56718–e56718. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuandong Zhu Breakdown of academic impact, for papers by Wanggang Zhang Breakdown of academic impact, for papers by Baodong Ye Breakdown of academic impact, for papers by Ting Jiang Breakdown of academic impact, for papers by Huijie Miao Breakdown of academic impact, for papers by K Nakamura Breakdown of academic impact, for papers by Yinji Jin Breakdown of academic impact, for papers by Elina Zorde‐Khvalevsky